A 12-week, Multicenter, Randomized, Double-blind, Double-dummy, 2-arm Parallel Group Study Comparing the Efficacy and Safety of Foster NEXThaler (Beclomethasone Dipropionate 100 microg Plus Formoterol 6 microg/Actuation), 2 Inhalations b.i.d., Versus Seretide Accuhaler (Fluticasone 250 microg Plus Salmeterol 50 microg/Actuation), 1 Inhalation b.i.d., on Small Airway Derived Parameters in Patients With Asthma
Phase of Trial: Phase III
Latest Information Update: 03 Apr 2017
At a glance
- Drugs Beclometasone/formoterol (Primary) ; Salmeterol/fluticasone propionate
- Indications Asthma
- Focus Therapeutic Use
- Acronyms NELSON
- Sponsors Chiesi Farmaceutici SpA
- 23 Jul 2014 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.
- 14 Feb 2014 According to the ClinicalTrials.gov record, planned end date changed from 1 Dec 2013 to 1 Feb 2014.
- 14 Feb 2014 According to the ClinicalTrials.gov record, status changed from recruiting to active, no longer recruiting.